{"id":"W4237577048","doi":"10.1200/jco.2015.33.15_suppl.e13528","title":"Development of a proposed biosimilar product based on the demonstration of physicochemical, pharmacologic and clinical similarity to filgrastim.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Filgrastim; Biosimilar; Medicine; Clinical endpoint; Pharmacology; Clinical trial; Oncology; Internal medicine; Neutropenia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000439047,0.0002554902,0.0001516648,0.0002489077,0.00009527363,0.0003110556,0.0002338634,0.0004693969,0.001495451],"category_scores_gemma":[0.0006432539,0.00007081611,0.0002743934,0.0001568872,0.0003407815,0.000234538,0.00026108,0.0005519154,0.0003739753],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002942308,"about_ca_system_score_gemma":0.0002636058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001507927,"about_ca_topic_score_gemma":0.0001809701,"domain_scores_codex":[0.9997887,0.00004091354,0.00001472906,0.00003503124,0.0001021269,0.0000184747],"domain_scores_gemma":[0.9997492,0.00003826548,0.00007907534,0.00003061708,0.00006297213,0.00003994409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002392646,0.0001549881,0.000391384,0.00006231538,0.00001148831,0.0001000873,0.00002344922,0.0002378753,0.9843346,0.0003580791,0.00014345,0.01394298],"study_design_scores_gemma":[0.0001826292,0.003921468,0.005343041,0.00001477128,0.00004871024,0.001929143,0.00001918185,0.002219439,0.9761754,0.0002534668,0.009880377,0.00001231931],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9681005,0.001228381,0.02540867,0.0003402959,0.00006032273,0.0005491188,0.0004845446,0.0001041635,0.003724015],"genre_scores_gemma":[0.975089,0.0004556669,0.02124527,0.0002004465,0.0000263786,0.0001184681,0.0008751462,0.000020491,0.00196913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001495451,"threshold_uncertainty_score":0.005002797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2755435968745606,"score_gpt":0.4906866541260698,"score_spread":0.2151430572515091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}